Genital warts treatment: Beyond imiquimod
Genital warts are one of the most common sexually transmitted diseases worldwide. The disease is a result of infection with low-risk types of human papillomaviruses, mostly type 6 and 11. Current therapies for genital warts are mainly ablative, or alternatively topical application of imiquimod cream...
Saved in:
Main Authors: | Jianwei Yuan (Author), Guoying Ni (Author), Tianfang Wang (Author), Kate Mounsey (Author), Shelley Cavezza (Author), Xuan Pan (Author), Xiaosong Liu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibitory mechanism of peptides with a repeating hydrophobic and hydrophilic residue pattern on interleukin-10
by: Guoying Ni, et al.
Published: (2017) -
A Perspective on Imiquimod Microneedles for Treating Warts
by: Tsu-Man Chiu, et al.
Published: (2021) -
Female Genital Warts: Global Trends and Treatments
by: Stanley A. Gall
Published: (2001) -
Clinical efficacy, safety and tolerance of the Kerawort (imiquimod) cream used for treatment of anogenital warts
by: M. R. Rakhmatulina, et al.
Published: (2017) -
Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task
by: Guoying Ni, et al.
Published: (2020)